시장보고서

상품코드

1790462

미국의 방부제 및 소독제 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 제품 유형별, 최종 용도별, 판매채널별, 부문별 예측(2025-2030년)

U.S. Antiseptic And Disinfectant Market Size, Share, & Trends Analysis Report By Type (Quaternary Ammonium Compounds, Enzyme, Other), By Product Type, By End Use, By Sales Channel, And Segment Forecasts, 2025 - 2030

발행일: 2025년 07월 | 리서치사:

Grand View Research | 페이지 정보: 영문 80 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

미국의 방부제 및 소독제 시장 요약

미국의 방부제 및 소독제 시장 규모는 2024년 94억 1,000만 달러로 2025년부터 2030년까지 연평균 10.8% 성장하여 2030년에는 170억 7,000만 달러에 달할 것으로 예측됩니다. 인플루엔자, A형 간염, 장티푸스, 콜레라, 뎅기열과 같은 질병의 유행 증가는 방부제 및 소독제 시장의 성장을 가속하는 주요 요인 중 하나입니다.

미국 질병예방통제센터(CDC)에 따르면, 2023-2024년 독감 시즌은 미국에서 약 4,000만 명의 질병, 47만 명의 입원, 28,000명의 사망을 초래했습니다. 의료 및 지역 사회 환경 모두에서 효과적인 소독의 필요성이 미국의 방부제 및 소독제 산업을 주도하고 있습니다. 미국에서는 외과 수술과 입원 환자 의료 절차가 증가하여 방부제 및 소독제 수요가 크게 증가했습니다. 각 시술은 의료 관련 감염 위험을 최소화하기 위해 엄격한 멸균 프로토콜과 무균 관행이 요구됩니다. 만성질환의 확산과 인구의 고령화는 입원율 상승에 기여하고 있습니다. 이러한 지속적인 환자 수 증가는 표면 오염의 위험을 증가시키고, 의료시설 전체에 걸쳐 일관되고 효과적인 소독 방법의 필요성을 강화합니다.

미국 환경보호청(EPA), 식품의약국(FDA) 등의 규제기관은 미국 산업 형성에 중요한 역할을 하고 있습니다. 이들 기관은 특히 헬스케어 환경에서 제품의 유효성, 안전성, 라벨링에 대한 엄격한 기준을 시행하고 있습니다. EPA는 병원용 소독제에 대해 광범위한 병원균에 대한 효과를 입증하기 위해 엄격한 시험을 의무화하고 있습니다. 한편, FDA는 환자에게 사용되는 소독약의 안전과 처방을 감독하고 있습니다. 이러한 규제 환경은 제조업체의 기술 혁신을 촉진하고 의료 서비스 제공업체가 규정을 준수하는 고품질 소독 솔루션을 채택하는 원동력이 되고 있습니다.

The U.S. antiseptic and disinfectant market size was valued at USD 9.41 billion in 2024 and is projected to reach USD 17.07 billion by 2030, growing at a CAGR of 10.8% from 2025 to 2030. An increase in the prevalence of diseases, such as influenza, hepatitis A, typhoid, cholera, and dengue, is one of the major factors driving the antiseptic & disinfectant market growth.

According to the Centers for Disease Control and Prevention (CDC), the 2023 - 2024 flu season led to an estimated 40 million illnesses, 470,000 hospitalizations, and 28,000 deaths in the U.S. The need for effective disinfection in both healthcare and community settings drives the U.S. antiseptic and disinfectant industry. The increasing number of surgical and inpatient medical procedures in the U.S. significantly drives demand for antiseptics and disinfectants. Each procedure requires stringent sterilization protocols and aseptic practices to minimize the risk of healthcare-associated infections. The growing prevalence of chronic diseases and an aging population are contributing to higher hospitalization rates. This sustained patient volume increases surface contamination risks, reinforcing the need for consistent and effective disinfection practices across healthcare facilities.

Regulatory organizations such as the U.S. Environmental Protection Agency (EPA) and the Food and Drug Administration (FDA) play a vital role in shaping the U.S. industry. These agencies enforce strict standards for product efficacy, safety, and labeling, particularly in healthcare environments. The EPA mandates that hospital-grade disinfectants undergo rigorous testing to prove effectiveness against a broad range of pathogens. Meanwhile, the FDA oversees the safety and formulation of antiseptics used on patients. This regulatory environment encourages manufacturers to innovate and drives healthcare providers to adopt compliant, high-quality disinfection solutions.

U.S. Antiseptic And Disinfectant Market Report Segmentation

This report forecasts revenue growth at the country level and analyzes the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. antiseptic and disinfectant market report based on type, product type, end use, and sales channel:

Type Outlook (Revenue, USD Million, 2018 - 2030)
Quaternary Ammonium Compounds
Chlorine Compounds
Alcohols & Aldehyde Products
Enzyme
Others
Product Type Outlook (Revenue, USD Million, 2018 - 2030)
Enzymatic Cleaners
Medical Device Disinfectants
Surface Disinfectants
End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Clinics
Other
Sales Channel Outlook (Revenue, USD Million, 2018 - 2030)
B2B
FMCG

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources and Third-Party Perspectives
- 1.3.4. Primary Research
1.4. Information Analysis
- 1.4.1. Data Analysis Models
1.5. Market Formulation and Data Visualization
1.6. Data Validation and Publishing

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Antiseptic And Disinfectant Market Variables, Trends and Scope

3.1. Market Lineage Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.2.3. Industry Challenge
3.3. Industry Analysis Tools
- 3.3.1. PORTER's Analysis
  - 3.3.1.1. Bargaining power of the suppliers
  - 3.3.1.2. Bargaining power of the buyers
  - 3.3.1.3. Threats of substitution
  - 3.3.1.4. Threats from new entrants
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Economic and social landscape
  - 3.3.2.3. Technological landscape

Chapter 4. U.S. Antiseptic And Disinfectant Market: Type Estimates and Trend Analysis

4.1. U.S. Antiseptic And Disinfectant Market, By Type: Key Takeaways
4.2. Type Movement Analysis and Market Share, 2024 and 2030
4.3. Market Estimates and Forecasts, By Type, 2018 - 2030 (USD Million)
- 4.3.1. Quaternary Ammonium Compounds
  - 4.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.2. Chlorine Compounds
  - 4.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.3. Alcohols & Aldehyde Products
  - 4.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.4. Enzyme
  - 4.3.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.5. Other
  - 4.3.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Antiseptic And Disinfectant Market: Product Type Estimates and Trend Analysis

5.1. U.S. Antiseptic And Disinfectant Market, By Product Type: Key Takeaways
5.2. Product Type Movement Analysis and Market Share, 2024 and 2030
5.3. Market Estimates and Forecasts, By Product Type, 2018 - 2030 (USD Million)
- 5.3.1. Enzymatic Cleaners
  - 5.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.2. Medical Device Disinfectants
  - 5.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.3. Surface Disinfectants
  - 5.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Antiseptic And Disinfectant Market: End Use Estimates and Trend Analysis

6.1. U.S. Antiseptic And Disinfectant Market, By End Use: Key Takeaways
6.2. End Use Movement Analysis and Market Share, 2024 and 2030
6.3. Market Estimates and Forecasts, By End Use, 2018 - 2030 (USD Million)
- 6.3.1. Hospitals
  - 6.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.2. Clinics
  - 6.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.3. Other
  - 6.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Antiseptic And Disinfectant Market: Sales Channel Estimates and Trend Analysis

7.1. U.S. Antiseptic And Disinfectant Market, By Sales Channel: Key Takeaways
7.2. Sales Channel Movement Analysis and Market Share, 2024 and 2030
7.3. Market Estimates and Forecasts, By Sales Channel, 2018 - 2030 (USD Million)
- 7.3.1. B2B
  - 7.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. FMCG
  - 7.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Company Categorization
8.2. Company Market Positioning
8.3. Company Heat Map Analysis
8.4. Company Profiles/Listing
- 8.4.1. 3M
  - 8.4.1.1. Company Overview
  - 8.4.1.2. Financial Performance
  - 8.4.1.3. Product Portfolio
  - 8.4.1.4. Recent Developments/ Strategic Initiatives
- 8.4.2. Reckitt Benckiser
  - 8.4.2.1. Company Overview
  - 8.4.2.2. Financial Performance
  - 8.4.2.3. Product Portfolio
  - 8.4.2.4. Recent Developments/ Strategic Initiatives
- 8.4.3. Steris Plc
  - 8.4.3.1. Company Overview
  - 8.4.3.2. Financial Performance
  - 8.4.3.3. Product Portfolio
  - 8.4.3.4. Recent Developments/ Strategic Initiatives
- 8.4.4. Kimberly-Clark Corporation
  - 8.4.4.1. Company Overview
  - 8.4.4.2. Financial Performance
  - 8.4.4.3. Product Portfolio
  - 8.4.4.4. Recent Developments/ Strategic Initiatives
- 8.4.5. Bio-Cide International, Inc.
  - 8.4.5.1. Company Overview
  - 8.4.5.2. Financial Performance
  - 8.4.5.3. Product Portfolio
  - 8.4.5.4. Recent Developments/ Strategic Initiatives
- 8.4.6. Cardinal Health
  - 8.4.6.1. Company Overview
  - 8.4.6.2. Financial Performance
  - 8.4.6.3. Product Portfolio
  - 8.4.6.4. Recent Developments/ Strategic Initiatives
- 8.4.7. BD
  - 8.4.7.1. Company Overview
  - 8.4.7.2. Financial Performance
  - 8.4.7.3. Product Portfolio
  - 8.4.7.4. Recent Developments/ Strategic Initiatives
- 8.4.8. Johnson & Johnson
  - 8.4.8.1. Company Overview
  - 8.4.8.2. Financial Performance
  - 8.4.8.3. Product Portfolio
  - 8.4.8.4. Recent Developments/ Strategic Initiatives

미국의 방부제 및 소독제 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 제품 유형별, 최종 용도별, 판매채널별, 부문별 예측(2025-2030년)

U.S. Antiseptic And Disinfectant Market Size, Share, & Trends Analysis Report By Type (Quaternary Ammonium Compounds, Enzyme, Other), By Product Type, By End Use, By Sales Channel, And Segment Forecasts, 2025 - 2030

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 미국의 방부제 및 소독제시장 변수, 동향, 범위

제4장 미국의 방부제 및 소독제시장 : 유형 추정·동향 분석

제5장 미국의 방부제 및 소독제시장 : 제품 유형 추정·동향 분석

제6장 미국의 방부제 및 소독제시장 : 최종 용도 추정·동향 분석

제7장 미국의 방부제 및 소독제시장 : 판매채널 추정·동향 분석

제8장 경쟁 구도

Table of Contents